DGPharma
ActiveSummary
DGPharma has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €300,586 and a net result of €158,798. Equity is growing by about 13% per year across the filed financial years. Its solvency ranks better than 34% of 12,411 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
30-06
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
2025
31-12
Financial
Highest result from 2018 to 2025net €158,798 ▲143%
Operating result €229,606, net result €158,798, both a record.
22-07
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format
2024
05-07
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format
2023
31-12
Financial
Equity above €500,000equity €506,480 ▲13.4%
A profit in every financial year since 2018 builds equity to €506,480.
31-08
NBB filing
Annual accounts filed
financial year 2022 · abbreviated format · 31 days late
2022
16-06
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format
2021
29-06
NBB filing
Annual accounts filed
financial year 2020 · abbreviated format
2020
04-08
NBB filing
Annual accounts filed
financial year 2019 · abbreviated format · 4 days late
2019
30-08
NBB filing
Annual accounts filed
financial year 2018 · abbreviated format · 30 days late
2018
28-06
NBB filing
Annual accounts filed
financial year 2017 · micro format
2017
14-06
NBB filing
Annual accounts filed
financial year 2016 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 13 annual accounts filed, the latest 10 are here; all 13 are under Financials.
0 of 9 deeds read
About the unread acts
We know of 9 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.